Metagenomi Inc. Common St...
(MGX)
undefined
undefined%
At close: undefined
3.32
0.15%
After-hours Dec 13, 2024, 07:52 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | 44.76M | 17.20M | 243.00K |
Cost of Revenue | 94.40M | 1.73M | 387.00K |
Gross Profit | -49.65M | 15.47M | -144.00K |
Operating Income | -78.49M | -44.64M | -23.95M |
Interest Income | 15.47M | 3.42M | 43.00K |
Pretax Income | -60.23M | -41.02M | -21.44M |
Net Income | -68.25M | -43.59M | -21.44M |
Selling & General & Admin | 28.84M | 18.70M | 9.71M |
Research & Development | 94.40M | 43.14M | 14.48M |
Other Expenses | - | 201.00K | 4.00K |
Operating Expenses | 123.25M | 61.84M | 24.19M |
Interest Expense | - | 98.00K | 302.00K |
Selling & Marketing Expenses | - | - | - |
Cost & Expenses | 123.25M | 61.84M | 24.19M |
Income Tax | 8.03M | 2.57M | 306.00K |
Shares Outstanding (Basic) | 37.53M | 29.96M | 29.96M |
Shares Outstanding (Diluted) | 37.53M | 29.96M | 29.96M |
EPS (Basic) | -1.82 | -1.45 | -0.72 |
EPS (Diluted) | -1.82 | -1.45 | -0.72 |
EBITDA | -56.02M | -39.19M | -20.75M |
Depreciation & Amortization | 4.21M | 1.73M | 387.00K |